SK Biopharmaceuticals Co Ltd
KRX:326030

Watchlist Manager
SK Biopharmaceuticals Co Ltd Logo
SK Biopharmaceuticals Co Ltd
KRX:326030
Watchlist
Price: 104 000 KRW -0.1% Market Closed
Market Cap: 8.1T KRW
Have any thoughts about
SK Biopharmaceuticals Co Ltd?
Write Note

SK Biopharmaceuticals Co Ltd
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

SK Biopharmaceuticals Co Ltd
Operating Expenses Peer Comparison

Comparables:
000100
008930
128940
S
000250
C
068760

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
SK Biopharmaceuticals Co Ltd
KRX:326030
Operating Expenses
-â‚©358.3B
CAGR 3-Years
-11%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Operating Expenses
-â‚©553.4B
CAGR 3-Years
2%
CAGR 5-Years
-7%
CAGR 10-Years
-9%
Hanmi Science Co Ltd
KRX:008930
Operating Expenses
-â‚©191.6B
CAGR 3-Years
-25%
CAGR 5-Years
-16%
CAGR 10-Years
-14%
Hanmi Pharm Co Ltd
KRX:128940
Operating Expenses
-â‚©612.8B
CAGR 3-Years
-6%
CAGR 5-Years
-5%
CAGR 10-Years
-5%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Operating Expenses
-â‚©91.9B
CAGR 3-Years
1%
CAGR 5-Years
-4%
CAGR 10-Years
-8%
C
Celltrion Pharm Inc
KOSDAQ:068760
Operating Expenses
-â‚©87.4B
CAGR 3-Years
-15%
CAGR 5-Years
-14%
CAGR 10-Years
-11%

See Also

What is SK Biopharmaceuticals Co Ltd's Operating Expenses?
Operating Expenses
-358.3B KRW

Based on the financial report for Dec 31, 2023, SK Biopharmaceuticals Co Ltd's Operating Expenses amounts to -358.3B KRW.

What is SK Biopharmaceuticals Co Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-21%

Over the last year, the Operating Expenses growth was -6%. The average annual Operating Expenses growth rates for SK Biopharmaceuticals Co Ltd have been -11% over the past three years , -21% over the past five years .

Back to Top